UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation

Translational research : the journal of laboratory and clinical medicine, 2017-05, Vol.183, p.87-103

2017

Volltextzugriff (PDF)

VCE‐004.3, a cannabidiol aminoquinone derivative, prevents bleomycin‐induced skin fibrosis and inflammation through PPARγ‐ and CB2 receptor‐dependent pathways

British journal of pharmacology, 2018-10, Vol.175 (19), p.3813-3831

2018

Volltextzugriff (PDF)

Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk

Frontiers in immunology, 2022-09, Vol.13

2022

Volltextzugriff (PDF)

Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cells

PloS one, 2015-06, Vol.10 (6), p.e0131363-e0131363

2015

Volltextzugriff (PDF)

Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission

Pediatric rheumatology online journal, 2020-07, Vol.18 (1), p.59-59, Article 59

2020

Volltextzugriff (PDF)

Assessment of the relationship between estimated cardiovascular risk and structural damage in patients with axial spondyloarthritis

Therapeutic advances in musculoskeletal disease, 2020, Vol.12, p.1759720X20982837-1759720X20982837

2020

Volltextzugriff (PDF)

Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approaches

Rheumatology (Oxford, England), 2016-12, Vol.55 (12), p.2096-2108

2016

Volltextzugriff (PDF)

New advances in genomics and epigenetics in antiphospholipid syndrome

Rheumatology (Oxford, England), 2024-02, Vol.63 (SI), p.SI14-SI23

2024

Volltextzugriff (PDF)

Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis

Therapeutic advances in musculoskeletal disease, 2019, Vol.11, p.1759720-1759720X19880742

2019

Volltextzugriff (PDF)

Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα

Arthritis research & therapy, 2015-03, Vol.17 (1), p.49-49, Article 49

2015

Volltextzugriff (PDF)

Sex-specific metabolic adaptations in transgenic mice overexpressing cytochrome b5 reductase-3

Free radical biology & medicine, 2023-10, Vol.207, p.144-160

2023

Volltextzugriff (PDF)

Editorial: Clinical management, pathogenesis and biomarkers of cardiovascular disease associated with systemic autoimmune disorders

Frontiers in immunology, 2022-11, Vol.13, p.1085875-1085875

2022

Volltextzugriff (PDF)

Fluctuation of Anti–Domain 1 and Anti–β2‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

Arthritis & rheumatology (Hoboken, N.J.), 2023-06, Vol.75 (6), p.984-995

2023

Volltextzugriff (PDF)

New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches

Frontiers in immunology, 2019-04, Vol.10, p.764-764

2019

Volltextzugriff (PDF)

Anticyclic citrullinated protein antibodies are implicated in the development of cardiovascular disease in rheumatoid arthritis

Arteriosclerosis, thrombosis, and vascular biology, 2014-12, Vol.34 (12), p.2706

2014

Volltextzugriff (PDF)

Standardization procedure for flow cytometry data harmonization in prospective multicenter studies

Scientific reports, 2020-07, Vol.10 (1), p.11567-11567, Article 11567

2020

Volltextzugriff (PDF)

Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS

Rheumatology (Oxford, England), 2019-10, Vol.58 (10), p.1870-1872

2019

Volltextzugriff (PDF)

Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs

Biomedicine & pharmacotherapy, 2024-04, Vol.173, p.116357-116357, Article 116357

2024

Volltextzugriff (PDF)

Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome

Annals of the rheumatic diseases, 2011-04, Vol.70 (4), p.675-682

2011

Volltextzugriff (PDF)

Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

Lupus, 2022-12, Vol.31 (14), p.1770-1776

2022

Volltextzugriff (PDF)

Altered S-nitrosothiol homeostasis provides a survival advantage to breast cancer cells in HER2 tumors and reduces their sensitivity to trastuzumab

Biochimica et biophysica acta, 2016-04, Vol.1862 (4), p.601-610

2016

Volltextzugriff (PDF)

Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNF-α therapy effectiveness

Journal of biomedical science, 2020-04, Vol.27 (1), p.54-54, Article 54

2020

Volltextzugriff (PDF)

Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid Arthritis

Frontiers in immunology, 2021-03, Vol.12, p.631662-631662

2021

Volltextzugriff (PDF)

Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens

Scientific reports, 2017-02, Vol.7 (1), p.43500-43500, Article 43500

2017

Volltextzugriff (PDF)

Proteomic approaches to evaluate protein s-nitrosylation in disease

Mass spectrometry reviews, 2014-01, Vol.33 (1), p.7-20

2014

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Aktive Filter

ThemaGene Expression

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(90)

Publikationsform

Artikel
(101)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(75)
Humans
(67)
Rheumatology
(28)
Female
(27)
Male
(21)
Adult
(19)
Hematology
(19)
Middle Aged
(18)
Antiphospholipid Syndrome
(17)
Immunology
(15)
Rheumatoid Arthritis
(14)
Biological And Medical Sciences
(13)
Thrombosis
(13)
Medical Sciences
(12)
Antiphospholipid Syndrome - Complications
(11)
Atherosclerosis
(10)
Autoimmune Diseases
(10)
Cardiovascular Disease
(10)
Inflammation
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation

VCE‐004.3, a cannabidiol aminoquinone derivative, prevents bleomycin‐induced skin fibrosis and inflammation through PPARγ‐ and CB2 receptor‐dependent pathways

Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk

Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cells

Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission

Assessment of the relationship between estimated cardiovascular risk and structural damage in patients with axial spondyloarthritis

Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approaches

New advances in genomics and epigenetics in antiphospholipid syndrome

Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis

Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα

Sex-specific metabolic adaptations in transgenic mice overexpressing cytochrome b5 reductase-3

Editorial: Clinical management, pathogenesis and biomarkers of cardiovascular disease associated with systemic autoimmune disorders

Fluctuation of Anti–Domain 1 and Anti–β2‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches

Anticyclic citrullinated protein antibodies are implicated in the development of cardiovascular disease in rheumatoid arthritis

Standardization procedure for flow cytometry data harmonization in prospective multicenter studies

Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS

Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs

Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome

Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

Altered S-nitrosothiol homeostasis provides a survival advantage to breast cancer cells in HER2 tumors and reduces their sensitivity to trastuzumab

Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNF-α therapy effectiveness

Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid Arthritis

Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens

Proteomic approaches to evaluate protein s-nitrosylation in disease

Aktive Filter

Suchergebnisse filtern